Genetics and genomics of pulmonary arterial hypertension.
By F. Soubrier, W. Chung, R. Machado, E. Grünig, M. Aldred, M. Geraci, J. Loyd, C. Elliott, R. Trembath, J. Newman and 1 more. Journal of the American College of Cardiology, 2013
724 citations recorded by the source corpus.
Subfields: Genetics, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/92df829a96729086eaa7913dcc4cc77c76bc99fa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Mechanisms of disease: pulmonary arterial hypertension (2011, background): “BMP receptor type 2 (BMPR2), ALK-1, and endoglin have been implicated as causal factors in hereditary and associated forms of PAH”
- Pulmonary arterial hypertension (2013, background): “5-40% of so called idiopathic PAH patients [6,11,108,119-123].”
- Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era (2015, background): “It has been reported mostly in HHT2, but has also been reported in HHT1 (Trembath et al., 2001; Soubrier et al., 2013).”
- Definitions and diagnosis of pulmonary hypertension. (2013, background): “A negative test in the context of a known mutation in a family member is reassuring, whereas a positive test can create significant psychological issues (51).”